Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Lidija Kovač & Zdenko Časar. (2020) A literature review of the patent application publications on cabotegravir – an HIV integrase strand transfer inhibitor. Expert Opinion on Therapeutic Patents 30:3, pages 195-208.
Read now
Read now
Malika Sharma & Sharon L Walmsley. (2014)
Raltegravir as antiretroviral therapy in HIV/AIDS. Expert Opinion on Pharmacotherapy 15:3, pages 395-405.
Read now
Read now
Catherine S Adamson, Karl Salzwedel & Eric O Freed. (2009) Virus maturation as a new HIV-1 therapeutic target. Expert Opinion on Therapeutic Targets 13:8, pages 895-908.
Read now
Read now
Articles from other publishers (49)
Shah Faisal, Syed Lal Badshah, Mohamed Sharaf & Mohnad Abdalla. (2022) Insight into the Hantaan virus RNA-dependent RNA polymerase inhibition using in-silico approaches. Molecular Diversity 27:6, pages 2505-2522.
Crossref
Crossref
Helene Borrmann, Görkem Ulkar, Anna E. Kliszczak, Dini Ismed, Mirjam Schilling, Andrea Magri, James M. Harris, Peter Balfe, Sridhar Vasudevan, Persephone Borrow, Xiaodong Zhuang & Jane A. McKeating. (2023) Molecular components of the circadian clock regulate HIV-1 replication. iScience 26:7, pages 107007.
Crossref
Crossref
Heba S. Abd-Ellah, Ramesh Mudududdla, Glen P. Carter & Jonathan B. Baell. (2023) Novel Perspectives on the Design and Development of a Long-Acting Subcutaneous Raltegravir Injection for Treatment of HIV—In Vitro and In Vivo Evaluation. Pharmaceutics 15:5, pages 1530.
Crossref
Crossref
Vladimir Finger, Martin Kufa, Ondrej Soukup, Daniele Castagnolo, Jaroslav Roh & Jan Korabecny. (2023) Pyrimidine derivatives with antitubercular activity. European Journal of Medicinal Chemistry 246, pages 114946.
Crossref
Crossref
Karen Reddy, Nirmal Renuka, Sheena Kumari & Faizal Bux. (2021) Algae-mediated processes for the treatment of antiretroviral drugs in wastewater: Prospects and challenges. Chemosphere 280, pages 130674.
Crossref
Crossref
Sangmi Oh, Yumi Park, Curtis A. Engelhart, Joshua B. Wallach, Dirk Schnappinger, Kriti Arora, Michelle Manikkam, Brian Gac, Hongwu Wang, Nicholas Murgolo, David B. Olsen, Michael Goodwin, Michelle Sutphin, Danielle M. Weiner, Laura E. Via, Helena I. M. Boshoff & Clifton E. BarryIIIIII. (2018)
Discovery and Structure–Activity-Relationship Study of
N
-Alkyl-5-hydroxypyrimidinone Carboxamides as Novel Antitubercular Agents Targeting Decaprenylphosphoryl-β-
d
-ribose 2′-Oxidase
. Journal of Medicinal Chemistry 61:22, pages 9952-9965.
Crossref
Crossref
Umesh Kalathiya, Monikaben Padariya & Maciej Baginski. (2018) Extracting functional groups of ALLINI to design derivatives of FDA-approved drugs: Inhibition of HIV-1 integrase. Biotechnology and Applied Biochemistry 65:4, pages 594-607.
Crossref
Crossref
Abayomi S. Olabode, Shaun M. Kandathil, Simon C. Lovell & David L. Robertson. (2017) Adaptive HIV-1 evolutionary trajectories are constrained by protein stability. Virus Evolution 3:2.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
687
736
.
Jie Chen, Cheng-Fu Liu, Cheng-Wen Yang, Cheng-Chu Zeng, Wei Liu & Li-Ming Hu. (2015) Design and synthesis of 5-chloro-2-hydroxy-3-triazolylbenzoic acids as HIV integrase inhibitors. Medicinal Chemistry Research 24:7, pages 2950-2959.
Crossref
Crossref
Zaigang Luo, Yu Zhao, Chao Ma, Zhipeng Li, Xuemei Xu, Liming Hu, Nianyu Huang & Hongqiu He. (2015) Synthesis, Biological Evaluation and Molecular Docking of Calix[4]arene-Based β-Diketo Derivatives as HIV-1 Integrase Inhibitors. Archiv der Pharmazie 348:3, pages 206-213.
Crossref
Crossref
Martin Markowitz, Teresa H. Evering, Donald Garmon, Marina Caskey, Melissa La Mar, Kristina Rodriguez, Vincent Sahi, Sarah Palmer, Nicole Prada & Hiroshi Mohri. (2014) A Randomized Open-Label Study of 3- Versus 5-Drug Combination Antiretroviral Therapy in Newly HIV-1–Infected Individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes 66:2, pages 140-147.
Crossref
Crossref
Bo-Wen Li, Feng-Hua Zhang, Erik Serrao, Huan Chen, Tino W. Sanchez, Liu-Meng Yang, Nouri Neamati, Yong-Tang Zheng, Hui Wang & Ya-Qiu Long. (2014) Design and discovery of flavonoid-based HIV-1 integrase inhibitors targeting both the active site and the interaction with LEDGF/p75. Bioorganic & Medicinal Chemistry 22:12, pages 3146-3158.
Crossref
Crossref
Thammarse S. Yamuna, Jerry P. Jasinski, Brian J. Anderson, H. S. Yathirajan & Manpreet Kaur. (2013) Raltegravir monohydrate. Acta Crystallographica Section E Structure Reports Online 69:12, pages o1743-o1744.
Crossref
Crossref
R. Nageswara Rao, K. Guru Prasad, K. V. Sravan Kumar & B. Ramesh. (2013) Diatomaceous earth supported liquid extraction and LC-MS/MS determination of elvitegravir and ritonavir in rat plasma: application to a pharmacokinetic study. Analytical Methods 5:23, pages 6693.
Crossref
Crossref
Supachai SakkhachornphopCarlos F. BarbasIIIIIIRassamee KeawvichitKanlaya WongworapatChatchai Tayapiwatana. (2012) Zinc Finger Protein Designed to Target 2-Long Terminal Repeat Junctions Interferes with Human Immunodeficiency Virus Integration. Human Gene Therapy 23:9, pages 932-942.
Crossref
Crossref
Nirpendra Singh, Atul Ranjan, Souvik Sur, Ramesh Chandra & Vibha Tandon. (2012) Inhibition of HIV-1 Integrase gene expression by 10-23 DNAzyme. Journal of Biosciences 37:3, pages 493-502.
Crossref
Crossref
Pawan Gupta, Prabha Garg & Nilanjan Roy. (2012) Identification of Novel HIV-1 Integrase Inhibitors Using Shape-Based Screening, QSAR, and Docking Approach. Chemical Biology & Drug Design 79:5, pages 835-849.
Crossref
Crossref
Xing Fan, Feng-Hua Zhang, Rasha I. Al-Safi, Li-Fan Zeng, Yumna Shabaik, Bikash Debnath, Tino W. Sanchez, Srinivas Odde, Nouri Neamati & Ya-Qiu Long. (2011) Design of HIV-1 integrase inhibitors targeting the catalytic domain as well as its interaction with LEDGF/p75: A scaffold hopping approach using salicylate and catechol groups. Bioorganic & Medicinal Chemistry 19:16, pages 4935-4952.
Crossref
Crossref
Meilan Huang, Guy H. Grant & W. Graham Richards. (2011) Binding modes of diketo-acid inhibitors of HIV-1 integrase: A comparative molecular dynamics simulation study. Journal of Molecular Graphics and Modelling 29:7, pages 956-964.
Crossref
Crossref
Angela Bailey. 2010. Nutrition and HIV. Nutrition and HIV
241
274
.
Francesca Ceccherini-Silberstein, Kurt Van Baelen, Daniele Armenia, Maria Trignetti, Evelien Rondelez, Lavinia Fabeni, Fernanda Scopelliti, Michela Pollicita, Liesbeth Van Wesenbeeck, Veerle Van Eygen, Luca Dori, Loredana Sarmati, Stefano Aquaro, Guido Palamara, Massimo Andreoni, Lieven J. Stuyver & Carlo Federico Perno. (2010) Secondary Integrase Resistance Mutations Found in HIV-1 Minority Quasispecies in Integrase Therapy-Naive Patients Have Little or No Effect on Susceptibility to Integrase Inhibitors. Antimicrobial Agents and Chemotherapy 54:9, pages 3938-3948.
Crossref
Crossref
Stefania Ferro, Laura De Luca, Maria Letizia Barreca, Sara De Grazia, Frauke Christ, Zeger Debyser & Alba Chimirri. (2010) New chloro,fluorobenzylindole derivatives as integrase strand-transfer inhibitors (INSTIs) and their mode of action. Bioorganic & Medicinal Chemistry 18:15, pages 5510-5518.
Crossref
Crossref
Fredy Guevara, Francisco Blanco & Miguel Arredondo. (2010) Inhibidores de la integrasa y raltegravir en el manejo de la infecci?n por virus de la inmunodeficiencia humana en la era de la resistencia a m?ltiples medicamentos. Infectio 14:2, pages 132-142.
Crossref
Crossref
Chiara Tommasi, Massimo Tempestilli, Rita Fezza, Rita Bellagamba, Emanuele Nicastri, Gianpiero D'Offizi, Leopoldo P Pucillo & Pasquale Narciso. (2010) A rare case of severe myopathy associated with etravirine use. AIDS 24:7, pages 1088-1090.
Crossref
Crossref
Sandrine Reigadas, Marie-Line Andr?ola, Linda Wittkop, Oph?lie Cosnefroy, Guerric Anies, Patricia Recordon-Pinson, Rodolphe Thi?baut, Bernard Masquelier & Herv? Fleury. (2010) Evolution of 2-long terminal repeat (2-LTR) episomal HIV-1 DNA in raltegravir-treated patients and in in vitro infected cells. Journal of Antimicrobial Chemotherapy 65:3, pages 434-437.
Crossref
Crossref
Jian-Hua Liu, Yi Jin & Ya-Qiu Long. (2010) Synthesis of the C5?C30 fragment of cyclodidemniserinol trisulfate via I2-mediated deprotection and ring closure tandem reaction. Tetrahedron 66:6, pages 1267-1273.
Crossref
Crossref
Luca Dori, Anna R Buonomini, Magda Viscione, Loredana Sarmati & Massimo Andreoni. (2010) A case of rhabdomiolysis associated with raltegravir use. AIDS 24:3, pages 473-475.
Crossref
Crossref
Annapurna Pendri, Timothy L. Troyer, Michael J. Sofia, Michael A. Walker, B. Narasimhulu Naidu, Jacques Banville, Nicholas A. Meanwell, Ira Dicker, Zeyu Lin, Mark Krystal & Samuel W. Gerritz. (2010) Solid Phase Synthesis of Novel Pyrrolidinedione Analogs as Potent HIV-1 Integrase Inhibitors. Journal of Combinatorial Chemistry 12:1, pages 84-90.
Crossref
Crossref
Supachai Sakkhachornphop, Supat Jiranusornkul, Kanchanok Kodchakorn, Sawitree Nangola, Thira Sirisanthana & Chatchai Tayapiwatana. (2009) Designed zinc finger protein interacting with the HIV-1 integrase recognition sequence at 2-LTR-circle junctions. Protein Science 18:11, pages 2219-2230.
Crossref
Crossref
Maria Letizia Barreca, Nunzio Iraci, Laura De Luca & Alba Chimirri. (2009) Induced-Fit Docking Approach Provides Insight into the Binding Mode and Mechanism of Action of HIV-1 Integrase Inhibitors. ChemMedChem 4:9, pages 1446-1456.
Crossref
Crossref
Sean Emery & Alan Winston. (2009) Raltegravir: a new choice in HIV and new chances for research. The Lancet 374:9692, pages 764-766.
Crossref
Crossref
Xue Zhi Zhao, Kasthuraiah Maddali, Christophe Marchand, Yves Pommier & Terrence R. BurkeJr.Jr.. (2009) Diketoacid-genre HIV-1 integrase inhibitors containing enantiomeric arylamide functionality. Bioorganic & Medicinal Chemistry 17:14, pages 5318-5324.
Crossref
Crossref
Xue Zhi Zhao, Kasthuraiah Maddali, B. Christie Vu, Christophe Marchand, Stephen H. Hughes, Yves Pommier & Terrence R. BurkeJr.Jr.. (2009) Examination of halogen substituent effects on HIV-1 integrase inhibitors derived from 2,3-dihydro-6,7-dihydroxy-1H-isoindol-1-ones and 4,5-dihydroxy-1H-isoindole-1,3(2H)-diones. Bioorganic & Medicinal Chemistry Letters 19:10, pages 2714-2717.
Crossref
Crossref
Stefania Notari, Chiara Tommasi, Emanuele Nicastri, Rita Bellagamba, Massimo Tempestilli, Leopoldo Paolo Pucillo, Pasquale Narciso & Paolo Ascenzi. (2009) Simultaneous determination of maraviroc and raltegravir in human plasma by HPLC-UV. IUBMB Life 61:4, pages 470-475.
Crossref
Crossref
Stéphane Hué, Robert J. Gifford, David Dunn, Esther Fernhill & Deenan Pillay. (2009) Demonstration of Sustained Drug-Resistant Human Immunodeficiency Virus Type 1 Lineages Circulating among Treatment-Naïve Individuals. Journal of Virology 83:6, pages 2645-2654.
Crossref
Crossref
Ahmad R Sedaghat, Robert F Siliciano & Claus O Wilke. (2009) Constraints on the dominant mechanism for HIV viral dynamics in patients on raltegravir. Antiviral Therapy 14:2, pages 263-271.
Crossref
Crossref
Eriketi Z. Loizidou, Ioanna Kousiappa, Constantinos D. Zeinalipour-Yazdi, David A. M. C. Van de Vijver & Leondios G. Kostrikis. (2008)
Implications of HIV-1 M Group Polymorphisms on Integrase Inhibitor Efficacy and Resistance: Genetic and Structural
in Silico
Analyses
. Biochemistry 48:1, pages 4-6.
Crossref
Crossref
Christoph BoeseckeLinda Gelgor. (2009) A Review of Raltegravir and its Use in HIV-1 Infection. Clinical Medicine. Therapeutics 1, pages CMT.S1985.
Crossref
Crossref
Katrien Busschots, Jan De Rijck, Frauke Christ & Zeger Debyser. (2009) In search of small molecules blocking interactions between HIV proteins and intracellularcofactors. Mol. BioSyst. 5:1, pages 21-31.
Crossref
Crossref
Alonso Heredia, Olga Latinovic, Robert C. Gallo, Gregory Melikyan, Marv Reitz, Nhut Le & Robert R. Redfield. (2008) Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1. Proceedings of the National Academy of Sciences 105:51, pages 20476-20481.
Crossref
Crossref
Srinivasan Ramanathan, Thomas N Kakuda, Rebecca Mack, Steve West & Brian P Kearney. (2008) Pharmacokinetics of Elvitegravir and Etravirine following Coadministration of Ritonavir-Boosted Elvitegravir and Etravirine. Antiviral Therapy 13:8, pages 1011-1017.
Crossref
Crossref
Jessica Marinello, Christophe Marchand, Bryan T. Mott, Anjali Bain, Craig J. Thomas & Yves Pommier. (2008) Comparison of Raltegravir and Elvitegravir on HIV-1 Integrase Catalytic Reactions and on a Series of Drug-Resistant Integrase Mutants. Biochemistry 47:36, pages 9345-9354.
Crossref
Crossref
Antonio MastrolorenzoAlfonso MarescaStefano RusconiClaudiu T Supuran. (2008) Update on the development of HIV entry inhibitors. Future HIV Therapy 2:5, pages 479-507.
Crossref
Crossref
Ileana StoicaS Kashif SadiqCatherine V GalePeter V Coveney. (2008) Virtual Physiological Human research initiative: the future for rational HIV treatment design?. Future HIV Therapy 2:5, pages 419-425.
Crossref
Crossref
Kazuya ShimuraEiichi Kodama. (2008) Elvitegravir: an emerging HIV integrase inhibitor. Future HIV Therapy 2:5, pages 411-418.
Crossref
Crossref
Li-Fan Zeng, Hu-Shan Zhang, Yun-Hua Wang, Tino Sanchez, Yong-Tang Zheng, Nouri Neamati & Ya-Qiu Long. (2008) Efficient synthesis and utilization of phenyl-substituted heteroaromatic carboxylic acids as aryl diketo acid isosteres in the design of novel HIV-1 integrase inhibitors. Bioorganic & Medicinal Chemistry Letters 18:16, pages 4521-4524.
Crossref
Crossref
Li-Fan Zeng, Xiao-Hua Jiang, Tino Sanchez, Hu-Shan Zhang, Raveendra Dayam, Nouri Neamati & Ya-Qiu Long. (2008) Novel dimeric aryldiketo containing inhibitors of HIV-1 integrase: Effects of the phenyl substituent and the linker orientation. Bioorganic & Medicinal Chemistry 16:16, pages 7777-7787.
Crossref
Crossref
Masaaki Takahashi, Mitsuru Konishi, Yuichi Kudaka, Naoya Okumura, Atsushi Hirano, Nami Terahata, Kazuhide Banno & Tsuguhiro Kaneda. (2008) A Conventional LC-MS Method Developed for the Determination of Plasma Raltegravir Concentrations. Biological & Pharmaceutical Bulletin 31:8, pages 1601-1604.
Crossref
Crossref